Anatara Lifesciences Ltd (AU:ANR) has released an update.
Don’t Miss TipRanks’ Half-Year Sale
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
- Make smarter investment decisions with TipRanks' Smart Investor Picks, delivered to your inbox every week.
Anatara Lifesciences Ltd successfully raised $274,500 through a Share Purchase Plan (SPP), complementing a recent $750,000 placement with institutional investors. The funds will support the company’s Phase II clinical study for its GaRP medication targeting irritable bowel syndrome and an anti-obesity project. This financial boost marks a significant step forward for Anatara’s innovative gastrointestinal and weight management solutions.
For further insights into AU:ANR stock, check out TipRanks’ Stock Analysis page.